Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
Early Estimate of Nirsevimab Effectiveness for Prevention of Respiratory Syncytial Virus-Associated Hospitalization Among Infants Entering Their First Respiratory Syncytial Virus Season - New Vaccine Surveillance Network, October 2023-February 2024.
复制标题
Nirsevimab 对进入第一个呼吸道合胞病毒季节的婴儿预防呼吸道合胞病毒相关住院的有效性的早期评估 - 新疫苗监测网络，2023 年 10 月至 2024 年 2 月。
DOI：
10.15585/mmwr.mm7309a4
复制
发表时间：
2024
期刊：
影响因子：
--
通讯作者：
中科院分区：
文献类型：
--
作者：
Moline,HeidiL;Tannis,Ayzsa;Toepfer,ArianaP;Williams,JohnV;Boom,JulieA;Englund,JanetA;Halasa,NatashaB;Staat,MaryAllen;Weinberg,GeoffreyA;Selvarangan,Rangaraj;Michaels,MarianG;Sahni,LeilaC;Klein,EileenJ;Stewart,LauraS;
